Novel retinoic acid 4-hydroxylase (CYP26) inhibitors based on a 3-(1H-imidazol- and triazol-1-yl)-2,2-dimethyl-3-(4-(phenyl-2-ylamino)phenyl)propyl scaffold

Gomaa, M., Bridgens, C., Illingworth, N., Veal, G. J., Redfern, C. P. F., Brancale, A, Armstrong, Jane and Simons, C. (2012) Novel retinoic acid 4-hydroxylase (CYP26) inhibitors based on a 3-(1H-imidazol- and triazol-1-yl)-2,2-dimethyl-3-(4-(phenyl-2-ylamino)phenyl)propyl scaffold. Bioorganic & Medicinal Chemistry, 20 (14). pp. 4201-4207. ISSN 0968-0896

Full text not available from this repository.

Search Google Scholar

Item Type: Article
Subjects: Sciences > Pharmacy and Pharmacology
Divisions: Faculty of Health Sciences and Wellbeing
Faculty of Health Sciences and Wellbeing > School of Pharmacy and Pharmaceutical Sciences
Faculty of Health Sciences and Wellbeing > School of Nursing and Health Sciences
Depositing User: Glenda Young
Date Deposited: 08 Jan 2013 09:29
Last Modified: 18 Dec 2019 15:34
URI: http://sure.sunderland.ac.uk/id/eprint/3296
ORCID for Jane Armstrong: ORCID iD orcid.org/0000-0002-5822-0597

Actions (login required)

View Item View Item